Literature DB >> 8552275

Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta.

S R Barnum1, J L Jones.   

Abstract

In this report, we examined interferon-gamma (IFN-gamma) and interleukin-1 beta (IL-1 beta)-mediated regulation of the expression of C3, the third component of complement, in a human astroglioma cell line. Interleukin-1 beta induced C3 protein expression ten-fold more rapidly than IFN-gamma. De novo protein synthesis was required for IFN-gamma to stimulate C3 expression, while cycloheximide and IL-1 beta treatment of cells markedly increased C3 expression. Actinomycin D, inhibited C3 gene induction by IFN-gamma and IL-1 beta suggesting that these cytokines act, in part, at the transcriptional level to enhance C3 expression. Understanding cytokine-mediated regulation of complement gene expression in the astrocyte is important in defining the role of these molecules in CNS inflammation and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552275     DOI: 10.1016/0304-3940(95)11923-k

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 2.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

3.  Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.

Authors:  Cornelia Speth; Thomas Schabetsberger; Iradji Mohsenipour; Gabriele Stöckl; Reinhard Würzner; Heribert Stoiber; Cornelia Lass-Flörl; Manfred P Dierich
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.

Authors:  C Speth; G Stöckl; I Mohsenipour; R Würzner; H Stoiber; C Lass-Flörl; M P Dierich
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Interleukin-1 beta stimulates mitogen-activated protein kinase in U373 astrocytoma cells without the production of lipid second messengers.

Authors:  A K Utal; A L Stopka; P D Coleman
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

Review 6.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

Review 7.  Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.

Authors:  Lori Broderick; Chhavi Gandhi; James L Mueller; Christopher D Putnam; Katayoon Shayan; Patricia C Giclas; Karin S Peterson; Seema S Aceves; Robert M Sheets; Bradley M Peterson; Robert O Newbury; Hal M Hoffman; John F Bastian
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

8.  Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review.

Authors:  R E Mrak; W St Griffin
Journal:  EOS       Date:  1996

Review 9.  Targeting the Complement Pathway in Malignant Glioma Microenvironments.

Authors:  Hongtao Zhu; Xingjiang Yu; Suojun Zhang; Kai Shu
Journal:  Front Cell Dev Biol       Date:  2021-04-01

10.  DDX5 promotes oncogene C3 and FABP1 expressions and drives intestinal inflammation and tumorigenesis.

Authors:  Nazia Abbasi; Tianyun Long; Yuxin Li; Brian A Yee; Benjamin S Cho; Juan E Hernandez; Evelyn Ma; Parth R Patel; Debashis Sahoo; Ibrahim M Sayed; Nissi Varki; Soumita Das; Pradipta Ghosh; Gene W Yeo; Wendy Jia Men Huang
Journal:  Life Sci Alliance       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.